Type 2 interleukin-4 receptor signaling in neutrophils antagonizes their expansion and migration during infection and inflammation J Woytschak, N Keller, C Krieg, D Impellizzieri, RW Thompson, TA Wynn, ... Immunity 45 (1), 172-184, 2016 | 134 | 2016 |
Clindamycin affects group a streptococcus virulence factors and improves clinical outcome F Andreoni, C Zürcher, A Tarnutzer, K Schilcher, A Neff, N Keller, ... The Journal of infectious diseases 215 (2), 269-277, 2017 | 108 | 2017 |
Role of Hypoxia Inducible Factor-1α (HIF-1α) in Innate Defense against Uropathogenic Escherichia coli Infection AE Lin, FC Beasley, J Olson, N Keller, RA Shalwitz, TJ Hannan, ... PLoS pathogens 11 (4), e1004818, 2015 | 86 | 2015 |
Detection of Streptococcus pyogenes M1UK in Australia and characterization of the mutation driving enhanced expression of superantigen SpeA MR Davies, N Keller, S Brouwer, MG Jespersen, AJ Cork, AJ Hayes, ... Nature Communications 14 (1), 1051, 2023 | 64 | 2023 |
Improved biodistribution and extended serum half-life of a bacteriophage endolysin by albumin binding domain fusion J Seijsing, AM Sobieraj, N Keller, Y Shen, AS Zinkernagel, MJ Loessner, ... Frontiers in microbiology 9, 2927, 2018 | 51 | 2018 |
A group A Streptococcus ADP-ribosyltransferase toxin stimulates a protective interleukin 1β-dependent macrophage immune response AE Lin, FC Beasley, N Keller, A Hollands, R Urbano, ER Troemel, ... MBio 6 (2), 10.1128/mbio. 00133-15, 2015 | 51 | 2015 |
Repurposing a neurodegenerative disease drug to treat Gram-negative antibiotic-resistant bacterial sepsis DMP De Oliveira, L Bohlmann, T Conroy, FEC Jen, A Everest-Dass, ... Science Translational Medicine 12 (570), eabb3791, 2020 | 44 | 2020 |
Integrative omics identifies conserved and pathogen-specific responses of sepsis-causing bacteria A Mu, WP Klare, SL Baines, CN Ignatius Pang, R Guérillot, ... Nature Communications 14 (1), 1530, 2023 | 25 | 2023 |
Phenol soluble modulin (PSM) variants of community-associated methicillin-resistant Staphylococcus aureus (MRSA) captured using mass spectrometry-based molecular networking DJ Gonzalez, L Vuong, IS Gonzalez, N Keller, D McGrosso, JH Hwang, ... Molecular & Cellular Proteomics 13 (5), 1262-1272, 2014 | 20 | 2014 |
Human streptococcal necrotizing fasciitis histopathology mirrored in a murine model N Keller, F Andreoni, C Reiber, H Luethi-Schaller, RA Schuepbach, ... The American journal of pathology 188 (7), 1517-1523, 2018 | 19 | 2018 |
Group A Streptococcal DNase Sda1 Impairs Plasmacytoid Dendritic Cells’ Type 1 Interferon Response N Keller, J Woytschak, LEM Heeb, EM Maggio, SM Shambat, J Snäll, ... Journal of Investigative Dermatology 139 (6), 1284-1293, 2019 | 18 | 2019 |
Human polyspecific immunoglobulin attenuates group A streptococcal virulence factor activity and reduces disease severity in a murine necrotizing fasciitis model A Tarnutzer, F Andreoni, N Keller, C Zürcher, A Norrby-Teglund, ... Clinical Microbiology and Infection 25 (4), 512. e7-512. e13, 2019 | 18 | 2019 |
Interferon α–Enhanced Clearance of Group A Streptococcus Despite Neutropenia S Uchiyama, N Keller, E Schlaepfer, C Grube, RA Schuepbach, RF Speck, ... The Journal of infectious diseases 214 (2), 321-328, 2016 | 14 | 2016 |
Rescuing Tetracycline Class Antibiotics for the Treatment of Multidrug-Resistant Acinetobacter baumannii Pulmonary Infection DMP De Oliveira, BM Forde, MD Phan, B Steiner, B Zhang, J Zuegg, ... Mbio 13 (1), e03517-21, 2022 | 12 | 2022 |
Immunoglobulin Attenuates Streptokinase-Mediated Virulence in Streptococcus dysgalactiae Subspecies equisimilis Necrotizing Fasciitis F Andreoni, F Ugolini, N Keller, A Neff, V Nizet, A Hollands, ... The Journal of infectious diseases 217 (2), 270-279, 2018 | 9 | 2018 |
Detection of Streptococcus pyogenes M1UK in Australia and characterization of the mutation driving enhanced expression of superantigen SpeA. Nat Commun 14: 1051 MR Davies, N Keller, S Brouwer, MG Jespersen, AJ Cork, AJ Hayes, ... | 7 | 2023 |
Neurodegenerative Disease Treatment Drug PBT2 Breaks Intrinsic Polymyxin Resistance in Gram-Positive Bacteria DMP De Oliveira, B Keller, AJ Hayes, CLY Ong, N Harbison-Price, ... Antibiotics 11 (4), 449, 2022 | 5 | 2022 |
Repurposing a neurodegenerative disease drug to treat Gram-negative antibiotic-resistant bacterial sepsis. Sci Transl Med 12: eabb3791 DMP De Oliveira, L Bohlmann, T Conroy, FE Jen, A Everest-Dass, ... | 5 | 2020 |
Characterization of a novel covS SNP identified in Australian group A Streptococcus isolates derived from the M1UK lineage J Richter, AJ Cork, Y Ong, N Keller, AJ Hayes, MA Schembri, AV Jennison, ... mBio, e03366-24, 2024 | | 2024 |
Investigating group A Streptococcus antibiotic tolerance in necrotizing fasciitis N Keller, M Boumasmoud, F Andreoni, A Tarnutzer, M von Matt, ... Msphere 9 (9), e00634-24, 2024 | | 2024 |